Human Immunology News Volume 8.42 | Oct 27 2020

    0
    68







    HIN 8.42 | Oct 27 2020


    Human Immunology News by STEMCELL Technologies
    Vol. 8.42 – 27 October, 2020
    TOP STORY

    Multimodal
    Mapping of the Tumor and Peripheral Blood Immune Landscape in Human Pancreatic Cancer

    Using a combination of CyTOF, single-cell RNA sequencing and multiplex immunohistochemistry on patient tumors, matched blood and non-malignant samples, scientists uncovered a complex network of immune-suppressive cellular interactions.
    [Nature Cancer]

    Abstract

    Tools and products for your COVID-19 research.
    PUBLICATIONSRanked by the impact factor of the journal

    Immune Receptor Inhibition through Enforced Phosphatase Recruitment

    Researchers present an alternative approach for attenuating cell-surface receptor signaling, termed receptor inhibition by phosphatase recruitment.
    [Nature]

    Abstract

    HLA-DR15
    Molecules Jointly Shape an Autoreactive T Cell Repertoire in Multiple Sclerosis

    Scientists characterized the immunopeptidomes of the two HLA-DR15 allomorphs DR2a and DR2b of human primary B cells and monocytes, thymus, and multiple sclerosis brain tissue.
    [Cell]

    Full ArticleGraphical Abstract

    Early-Onset Autoimmunity Associated with SOCS1 Haploinsufficiency

    By whole-exome/genome sequencing, researchers identified heterozygous, autosomal-dominant, germline loss-of-function mutations in the SOCS1 gene in ten patients from five unrelated families with early onset autoimmune manifestations.
    [Nature Communications]

    Full Article

    A
    Trispecific Killer Engager Molecule Against CLEC12A Effectively Induces NK-Cell Mediated Killing of AML Cells

    To target acute myeloid leukemia (AML) blasts and leukemic stem cells using NK cells, scientists developed a trispecific killer engager molecule containing a humanized anti-CD16 heavy chain camelid single-domain antibody that activates NK cells.
    [Leukemia]

    Abstract

    Irreversible
    Electroporation Plus Allogenic Vγ9Vδ2 T Cells Enhances Antitumor Effect for Locally Advanced Pancreatic Cancer Patients

    The authors investigated the antitumor efficacy of irreversible electroporation plus allogeneic γδ T cells in locally advanced pancreatic cancer patients.
    [Signal Transduction and Targeted Therapy]

    Full Article

    Exosomal
    LGALS9 in the Cerebrospinal Fluid of Glioblastoma Patients Suppressed Dendritic Cell Antigen Presentation and Cytotoxic T-Cell Immunity

    Researchers found that glioblastoma multiforme-cerebrospinal fluid-exosomes (GBM-CSF-Exos) contained a unique protein, LGALS9 ligand, which bound to the TIM3 receptor of dendritic cells (DCs) in the CSF to inhibit antigen recognition, processing and presentation by DCs, leading to failure of the cytotoxic T-cell-mediated antitumor immune response.
    [Cell Death & Disease]

    Full Article

    Gene
    Expression Analysis in Formalin Fixed Paraffin Embedded Melanomas Is Associated with Density of Corresponding Immune Cells in Those Tissues

    Investigators hypothesized that gene expression profiling of human melanomas using a new RNA expression technology in formalin-fixed paraffin-embedded tissue would correlate with the same immune cells identified by immunohistochemistry. [Scientific Reports]

    Full Article

    Quantitative
    PCR Methodology with a Volume-Based Unit for the Sophisticated Cellular Kinetic Evaluation of Chimeric Antigen Receptor T Cells

    Researchers established a novel qPCR methodology incorporating a spike-in calibration curve that expressed cellular kinetics in units of copies/μL blood, as was the case for conventional pharmacokinetic studies of small molecules and other biologics.
    [Scientific Reports]

    Full Article

    Mesenchymal
    Stem Cells: a Potential Treatment Approach for Refractory Chronic Spontaneous Urticaria

    Scientists found that the T cell subsets and inflammatory molecules were not affected by mesenchymal stem cell treatment during the follow-up period. In control patients, a significant decrease was detected only at the Th2 subset, TGF-β1, PGE2, IDO and anti-FcεRI levels on the 14th day of treatment.
    [Stem Cell Reviews and Reports]

    Abstract

    New human primary cell products—frozen leukopaks, regulatory T cells, and more. Click to view products.
    REVIEWS

    T Cell Regeneration after Immunological Injury

    The authors focus on the causes and consequences of impaired adaptive immunity and discuss therapeutic strategies that can recover immune function, with a particular emphasis on approaches that can promote a diverse repertoire of T cells through de novo T cell formation.
    [Nature Reviews Immunology]

    Full Article

    INDUSTRY AND POLICY NEWS

    Trans-Hit
    Biomarkers Announces Today a Partnership with Nexelis, Supporting Sample Procurement Activities for a Number of Strategic Projects Including COVID-19 Vaccines and Immuno-Oncology Development Initiatives

    Trans-Hit Biomarkers Inc. announced the signing of a partnership agreement with Laboratoires Nexelis Canada Inc. to support prophylactic and therapeutic vaccine development programs sponsored by global pharmaceutical companies, innovative biotechnology companies, and prestigious governmental and non-governmental organizations.
    [Trans-Hit Biomarkers, Inc.]

    Press Release

    FEATURED EVENT

    Neurodegenerative Diseases: Biology & Therapeutics

    December 2 – December 4
    Virtual


    > See All Events

    JOB OPPORTUNITIES

    Research
    Positions – Cancer and Immunotherapy

    Terasaki Research Institute – Los Angeles, California, United States

    Postdoctoral Fellow – Cancer Immunology and Immunotherapy

    H. Lee Moffitt Cancer Center & Research Institute – Tampa, Florida, United States


    Postdoctoral Fellowship – Innate Immunity and DNA Repair

    Stockholm University – Stockholm, Sweden

    Scientist Position – Skin Immunology

    University of California, Davis – Sacramento, California, United States

    Postdoctoral
    Associate – Immune Modulatory Therapies

    Houston Methodist Research Institute – Houston, Texas, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Science News Human Immunology News
    Archives Contact Us
    Human Immunology News Twitter